156
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Multi-exon deletions of the FBN1 gene in Marfan syndrome

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Mutations in the fibrillin -1 gene (FBN1) cause Marfan syndrome (MFS), an autosomal dominant multi-system connective tissue disorder. The 200 different mutations reported in the 235 kb, 65 exon-containing gene include only one family with a genomic multi-exon deletion.

          Methods

          We used long-range RT-PCR for mutation detection and long-range genomic PCR and DNA sequencing for identification of deletion breakpoints, allele-specific transcript analyses to determine stability of the mutant RNA, and pulse-chase studies to quantitate fibrillin synthesis and extracellular matrix deposition in cultured fibroblasts. Southern blots of genomic DNA were probed with three overlapping fragments covering the FBN1 coding exons

          Results

          Two novel multi-exon FBN1 deletions were discovered. Identical nucleotide pentamers were found at or near the intronic breakpoints. In a Case with classic MFS, an in-frame deletion of exons 42 and 43 removed the C-terminal 24 amino acids of the 5 th LTBP (8-cysteine) domain and the adjacent 25 th calcium-binding EGF-like (6-cysteine) domain. The mutant mRNA was stable, but fibrillin synthesis and matrix deposition were significantly reduced. A Case with severe childhood-onset MFS has a de novo deletion of exons 44–46 that removed three EGF-like domains. Fibrillin protein synthesis was normal, but matrix deposition was strikingly reduced. No genomic rearrangements were detected by Southern analysis of 18 unrelated MFS samples negative for FBN1 mutation screening.

          Conclusions

          Two novel deletion cases expand knowledge of mutational mechanisms and genotype/phenotype correlations of fibrillinopathies. Deletions or mutations affecting an LTBP domain may result in unstable mutant protein cleavage products that interfere with microfibril assembly.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: not found
          • Article: not found

          The human gene mutation database.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Marfan syndrome.

            The Marfan syndrome (MFS), initially described just over 100 years ago, was among the first conditions classified as a heritable disorder of connective tissue. MFS lies at one end of a phenotypic continuum, with people in the general population who have one or another of the features of MFS at the other end, and those with a variety of other conditions in between. Diagnosis of MFS and these other conditions remains based on clinical features. Mutations in FBN1, the gene that encodes fibrillin-1, are responsible for MFS and (in a few patients) other disorders in the continuum. In addition to skeletal, ocular, and cardiovascular features, patients with MFS have involvement of the skin, integument, lungs, and muscle tissue. Over the past 30 years, evolution of aggressive medical and surgical management of the cardiovascular problems, especially mitral valve prolapse, aortic dilatation, and aortic dissection, has resulted in considerable improvement in life expectancy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.

              The extracellular microfibril, 10-14 nm in diameter, performs a number of functions, including serving as the scaffolding for deposition of tropoelastin to form elastic fibers. A variety of proteins compose the structure of microfibrils, the most prominent of which are the two fibrillins. Fibrillin-1 is encoded by FBN1 on human chromosome 15q21 and fibrillin-2 is encoded by FBN2 on 5q23. Each fibrillin monomer contains a large number of epidermal growth factor-like motifs, most capable of binding calcium ions, and a few motifs resembling the binding protein for transforming growth factor beta. In vitro polymerization of fibrillin monomers produces 'beads on a string' structures that look on electron microscopy much like microfibrils purified from the extracellular matrices of a variety of tissues. Mutations in FBN1 produce Marfan syndrome, a pleiotropic autosomal dominant connective tissue disorder with prominent manifestations in the skeleton, eye and cardiovascular system. A number of conditions related to Marfan syndrome are also due to FBN1 mutations. Contractural arachnodactyly is due to mutations in FBN2. In this paper we review the published mutations in these genes, preliminary results of genotype-phenotype correlations, and speculations regarding molecular pathogenesis.
                Bookmark

                Author and article information

                Journal
                BMC Med Genet
                BMC Medical Genetics
                BioMed Central (London )
                1471-2350
                2001
                24 October 2001
                : 2
                : 11
                Affiliations
                [1 ]Howard Hughes Medical Institute and Department of Genetics, Stanford University Medical Center, Stanford, CA, USA
                [2 ]Department of Pathology, Stanford University Medical Center, Stanford, CA, USA
                [3 ]Current address: Gene Identification Laboratory, Department of Laboratory Medicine, 812 Hilton, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
                [4 ]Current address: Department of Pathology, Stanford University Medical Center, Stanford, CA 94305-5324, USA
                [5 ]Current address: Departments of Pathology, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115-6195, USA
                [6 ]Current address: Beckman Center for Molecular and Genetic Medicine, Room B201, 279 Campus Drive, Stanford University School of Medicine, Stanford, CA 94305-5323, USA
                Article
                1471-2350-2-11
                10.1186/1471-2350-2-11
                59835
                11710961
                f5515717-594a-4f2f-aed6-ba04b971216a
                Copyright © 2001 Liu et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
                History
                : 12 September 2001
                : 24 October 2001
                Categories
                Research Article

                Genetics
                Genetics

                Comments

                Comment on this article